FDA oversight of clinical trials is "grossly inadequate," say experts
BMJ
.
2022 Nov 16:379:o2628.
doi: 10.1136/bmj.o2628.
Author
Maryanne Demasi
1
Affiliation
1
Sydney, Australia.
PMID:
36384738
DOI:
10.1136/bmj.o2628
No abstract available
MeSH terms
Clinical Trials as Topic*
Humans
United States
United States Food and Drug Administration*